Akanda (NASDAQ:AKAN) Stock Moved Up to “Sell” by Wall Street Zen

Wall Street Zen upgraded shares of Akanda (NASDAQ:AKAN) from a strong sell rating to a sell rating in a report published on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Akanda in a research report on Thursday, August 13th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Akanda Trading Down 10.4%

Akanda stock opened at $1.98 on Friday. Akanda has a 52 week low of $1.94 and a 52 week high of $78.90. The stock has a 50-day moving average price of $4.06 and a 200 day moving average price of $9.92.

Akanda (NASDAQ:AKAN) last posted its quarterly earnings data on Wednesday, September 30th. The company reported ($5.90) earnings per share for the quarter. The firm had revenue of $0.20 million for the quarter.

Akanda Company Profile

Akanda Corporation is an international medical cannabis company focused on the cultivation, processing, distribution and sale of cannabis products. Its activities have included medical cannabis flower, oils and other formulations intended for patients and healthcare markets.

The company has historically operated through businesses serving the European medical cannabis industry. Its operations have included cultivation and processing activities in Portugal, as well as CanMart, a United Kingdom-based importer and distributor of pharmaceutical-grade medical cannabis products.